site stats

Curr cancer drug targets 影响因子

WebAbstract. Background: Multiple myeloma (MM) is a hematological cancer caused by a proliferation of clonal plasma cells, leading to anemia, renal failure, hypercalcemia and destructive bone lesions resulting in significant morbidity. The overall survival has significantly improved with the incorporation of immunomodulatory drugs (IMiDs) and ... WebMay 31, 2024 · Due to the advantages in efficacy and safety compared with traditional chemotherapy drugs, targeted therapeutic drugs have become mainstream cancer …

Current Cancer Drug Targets - Academic Accelerator

WebTargeting the ubiquitin-proteasome pathway has emerged as a rational approach in the treatment of human cancer. Based on positive preclinical and clinical studies, bortezomib was subsequently approved for the clinical use as a front-line treatment for newly diagnosed multiple myeloma patients and for the treatment of relapsed/refractory multiple myeloma … Web在文章类型上,论著和综述文章是大头,数量参半,还有少量的社论文章。Web of Science已收录的文章中,论著文章1308篇,综述文章1109篇。 影响因子. 2024年6月,Cancers与Cells杂志同时获得首个SCI影响因子,Cancers的分数略高,而且破5分,这关注度自然要更 … bivalent booster singapore location https://uasbird.com

Mutational Testing in Gastrointestinal Stromal Tumor - PubMed

WebTargeting highly proliferating cells is an important issue for many types of aggressive tumors. Proliferating Cell Nuclear Antigen (PCNA) is an essential protein that participates in a variety of processes of DNA metabolism, including DNA replication and repair, chromatin organization and transcription and sister chromatid cohesion. WebThe current review article describes some of these promising anticancer targets that include kinases, tubulin, cancer stem cells, monoclonal antibodies and vascular targeting agents. In addition, promising drug candidates under … WebCurrent Cancer Drug Targets is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Ruiwen Zhang ( UH Drug Discovery Institute). The journal covers research on contemporary molecular drug targets involved in cancer, including medicinal chemistry, pharmacology, molecular biology, genomics, and ... datedif not available

Welcome to Bentham Science Publisher

Category:CURRENT CANCER DRUG TARGETS-期刊论坛,投稿经验-MedSci.cn

Tags:Curr cancer drug targets 影响因子

Curr cancer drug targets 影响因子

Expert Opinion on Therapeutic Targets Taylor & Francis Online

http://www.nativeee.com/index.php/news/434.html WebPubMed Central (PMC)链接:PubMed Central 平均审稿速度:网友分享经验:一般,3-8周 平均录用比例:网友分享经验:较难 在线出版周期:

Curr cancer drug targets 影响因子

Did you know?

WebPubMed Central (PMC)链接:PubMed Central 平均审稿速度:网友分享经验:平均1月 平均录用比例:网友分享经验:约50% 在线出版周期: WebApr 5, 2024 · Expert Opinion on Therapeutic Targets (ISSN 1472-8222 [print], 1744-7631 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles and original papers on novel molecular targets, providing expert opinion on the scope for future drug development and the impact on drug discovery.. The journal …

WebAug 17, 2024 · 肿瘤学(ONCOLOGY)领域SCIE期刊及2024年影响因子排名part1. 哪些肿瘤学(ONCOLOGY)SCI期刊容易发表?. 影响因子是衡量期刊水平的重要指标,一般 … Web《current cancer drug targets》发布于爱科学网,并永久归类相关sci期刊导航类别中,本站只是硬性分析 "《curr cancer drug tar》" 杂志的可信度。学术期刊真正的价值在于它 …

WebAug 15, 2024 · BTC is a rare and aggressive cancer disease, bearing an overall dismal prognosis with only finite therapy options. Only combination chemotherapy regimens achieve disease control, which is often only short-lived since the tumor tissue exhibits high resistance to chemotherapy. ... Curr Cancer Drug Targets. 2024 Aug 15;22(8):639-650. … WebCurrent Cancer Drug Targets(当前的抗癌药物靶点)创刊于2001年,由BENTHAM SCIENCE PUBL LTD出版商出版,收稿方向涵盖医学 - 肿瘤学全领域,此期刊水平偏中 …

Web介绍. Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics …

Web期刊名称. CURR PROB CANCER/CURRENT PROBLEMS IN CANCER. ISSN. 0147-0272. 影响指数话题. 影响指数话题. 预警等级. MedSci期刊指数. 6.769 (MedSci实时期刊指数) 5.25578 (5年期刊指数). datedif office2016Web介绍. Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics … datedif not in excel 2016WebCURRENT CANCER DRUG TARGETS. 出版年份:2001 年文章数:29 投稿命中率:43.75%. 出版周期:Monthly 自引率:1.2% 审稿周期:平均2.4月. 前往期刊查询. 期刊 … bivalent booster which oneWebCurrent Oncology is an international, peer-reviewed , open access journal published online by MDPI (from Volume 28 Issue 1-2024). The journal changes publication frequency from bimonthly to monthly in 2024. Established in 1994, the journal represents a multidisciplinary medium for clinical oncologists to report and review progress in the ... bivalent booster without primary seriesWebCurr Cancer Drug Targets. 2024;21(7):558-574. doi: 10.2174/1568009621666210504091722. ... The microenvironment of gliomas includes non-cancer cells such as immune cells, fibroblasts, and cells of blood vessels, as well as secreted molecules and the extracellular matrix, and all these components play a vital … datedif orWebBentham Science Publishers. Bentham Science is a science, technology, and medical publisher, providing academic researchers and industrial professionals with the latest … Anti-Cancer Agents in Medicinal Chemistry ISSN (Print):1871-5206 ISSN … Articles By Disease - Welcome to Bentham Science Publisher Reprints are customized, reproductions of articles printed on high-quality paper for … Online Manuscript Submission and Tracking System: The Manuscript Processing … By Subject - Welcome to Bentham Science Publisher Recent Patents on Anti-Cancer Drug Discovery. ISSN: 2212-3970 (Online) … Anti-Cancer Agents in Medicinal Chemistry ISSN (Print):1871-5206 ISSN … Recent Patents on Anti-Cancer Drug Discovery . Impact Factor: 3.038 5-Year … Journal Catalog 2024. Catalog Description: Bentham Science Publishers’ 2024 … bivalent booster which is betterWeb影响因子 IF 热搜. 2 ... Biomimetics Cell Stem Cell Pharmaceutical Biology PPAR Research Pharmacogenetics and Genomics Archives of Pharmacal Research Current Cancer Drug Targets Pharmacogenomics Journal EXCLI Journal Journal of Pharmacological Sciences MedChemComm Phytochemical Analysis Molecular Imaging Molecular ... pre-clinical … bivalent booster who can get it